Emulation of the control cohort of a randomized controlled trial in pediatric kidney transplantation with Real-World Data from the CERTAIN Registry.

Autor:	Patry, Christian, Sauer, Lukas D., Sander, Anja, Krupka, Kai, Fichtner, Alexander, Brezinski, Jolanda, Geissbühler, Yvonne, Aubrun, Elodie, Grinienko, Anna, Strologo, Luca Dello, Haffner, Dieter, Oh, Jun, Grenda, Ryszard, Pape, Lars, Topaloğlu, Rezan, Weber, Lutz T., Bouts, Antonia, Kim, Jon Jin, Prytula, Agnieszka, König, Jens
Předmět:	RESEARCH KIDNEY failure URINARY tract infections KIDNEY transplantation PEDIATRICS GRAFT survival RANDOMIZED controlled trials COMPARATIVE studies PROTEINURIA RESEARCH funding CLINICAL trial registries TRANSPLANTATION of organs tissues etc. CHILDREN
Zdroj:	Pediatric Nephrology; May2023, Vol. 38 Issue 5, p1621-1632, 12p, 1 Diagram, 4 Charts, 1 Graph
Abstrakt:	Background: Randomized controlled trials in pediatric kidney transplantation are hampered by low incidence and prevalence of kidney failure in children. Real-World Data from patient registries could facilitate the conduct of clinical trials by substituting a control cohort. However, the emulation of a control cohort by registry data in pediatric kidney transplantation has not been investigated so far. Methods: In this multicenter comparative analysis, we emulated the control cohort (n = 54) of an RCT in pediatric kidney transplant patients (CRADLE trial; ClinicalTrials.gov NCT01544491) with data derived from the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN) registry, using the same inclusion and exclusion criteria (CERTAIN cohort, n = 554). Results: Most baseline patient and transplant characteristics were well comparable between both cohorts. At year 1 posttransplant, a composite efficacy failure end point comprising biopsy-proven acute rejection, graft loss or death (5.8% ± 3.3% vs. 7.5% ± 1.1%, P = 0.33), and kidney function (72.5 ± 24.9 vs. 77.3 ± 24.2 mL/min/1.73 m2P = 0.19) did not differ significantly between CRADLE and CERTAIN. Furthermore, the incidence and severity of BPAR (5.6% vs. 7.8%), the degree of proteinuria (20.2 ± 13.9 vs. 30.6 ± 58.4 g/mol, P = 0.15), and the key safety parameters such as occurrence of urinary tract infections (24.1% vs. 15.5%, P = 0.10) were well comparable. Conclusions: In conclusion, usage of Real-World Data from patient registries such as CERTAIN to emulate the control cohort of an RCT is feasible and could facilitate the conduct of clinical trials in pediatric kidney transplantation. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.